Novavax (NVAX) Reports Q3 Loss of $3.21/sh
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.80 -0.28%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($3.21), versus $0.74 reported last year. Revenue for the quarter came in at $157 million versus the consensus estimate of $230.56 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Activist Jana Partners calls for Six Flags sale - WSJ
- TD Cowen on Alaska Air (ALK): 'Can Alaska ReAccelerate?'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
